跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
STEI-16 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
STEI-16
Approved
STANDARD
STEI-16
Sriprasit Pharma Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9f5207f88e4ff975
Company
Sriprasit Pharma Co., Ltd.
Type
Standard
Approval Details
Approval Id
9f5207f88e4ff975
Drug Approval Philippines Name
STEI-16
Product Name
STEI-16
Registration Number
DRP-11790
Brand Name
STEI-16
Generic Name
Betahistine hydrochloride
Dosage Form
Tablet
Dosage Strength
16mg
Manufacturer
Sriprasit Pharma Co., Ltd.
Importer
Euro-Care Products Philippines
Distributor
Euro-Care Products Philippines
Issuance Date
28 April 2022
Expiry Date
28 April 2027
Pharmacologic Category
Antivertigo
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9f5207f88e4ff975
Type
Standard
Back to Philippines FDA Approvals